Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 3 4Phase 4 3Phase 1 2

Status

Unknown 3Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 1Nasopharyngeal Carcinoma 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Carboplatin 190Cisplatin 156Pemetrexed 151Paclitaxel 127Docetaxel 109pembrolizumab 87Gemcitabine 73Erlotinib Hydrochloride 44Radiotherapy 39Vinorelbine 35Gefitinib 34durvalumab 31Bevacizumab 28Nivolumab 26Drug Therapy 23atezolizumab 22osimertinib 19130-nm albumin-bound paclitaxel 19tislelizumab 16Crizotinib 16Radiosurgery 15Etoposide 14Surgical Procedures, Operative 11Afatinib 11Ipilimumab 10icotinib 9aumolertinib 9Albumin-Bound Paclitaxel 9Specimen Handling 8Observation 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Non-Small-Cell Lung × endostar protein × Clear all
NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Xinqiao Hospital of Chongqing

Phase 3 Unknown
134 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02001168 2013-12-04

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in Phaseâ… B

Xinjiang Medical University

Phase 3 Unknown
392 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01124253 2010-05-17

Dengshan

Shanghai Jiao Tong University School of Medicine

Phase 3 Completed
250 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00576914 2010-03-09

Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer

Chinese Academy of Sciences

Phase 3 Unknown
1,108 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡